Swiss Pharma Shock: Novartis’ experimental del-desiran fails a late-stage trial for myotonic dystrophy type 1, dragging Novartis shares sharply and rattling rare-disease peers like Dyne and Sarepta. Market Mood: Europe’s stocks were broadly flat as oil pushed sentiment; Zurich’s SMI slid on the Novartis sell-off while Brent edged toward $100 amid Middle East supply fears. Swiss Corporate Moves: Sandoz laid out a biosimilars push, targeting more than double net sales by 2035 and expanding its biosimilars portfolio. Banking & Markets Infrastructure: SIX and TWINT joined a Swiss stablecoin sandbox, while UBS is raising AI expectations for junior bankers. Swiss Tech/Industry: ABB’s Machine Automation division eyes Penang as a Southeast Asia hub; Stäubli highlighted connectivity needs for semiconductor tool uptime. Travel & Aviation: Wizz Air expands Armenia capacity, adding a fourth aircraft and new routes including Basel. Education Benchmark: PISA 2025 shows many countries beating the US, with Switzerland among those outperforming in at least one subject.
AGP Executive Report
Your go-to archive of top headlines, summarized for quick and easy reading.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Swiss Digital Sovereignty: Switzerland is piloting alternatives to Microsoft 365 to cut reliance on US tech and better control sensitive federal data, with a trial that could shift about 3,000 workstations. Capital Markets & Tech: SIX launched “SIX Market Signal” with a real-time 1BBO feed for Swiss, UK and 16 EU markets, aiming to serve both institutions and retail investors. Insurer Platform Upgrade: Zurich expanded its SME e-trading offering on Acturis Open Market and Zurich Online, adding 1,400+ trades to broaden brokers’ liability-only options. Pharma Watch: Novartis faces another setback as del-desiran fails a crucial phase 3 endpoint, adding pressure as it looks for growth beyond its Avidity pipeline. Biotech Strategy: Sandoz reaffirmed its Bio100 pivot to biosimilars, targeting mid-to-high single-digit net sales growth to 2030 and a core EBITDA margin of 25–27% by 2030. Crypto Infrastructure in Switzerland: Fuze Finance won SO-FIT approval to expand into Switzerland, offering crypto-asset infrastructure and stablecoin settlement alongside SWIFT/SEPA/SIC rails.
Robotics Race: Europe staged a push to become a “robot superpower” with demonstrations in Brussels, showing slow-but-precise home and recycling robots—while researchers warn the gap is now political will and funding, not science. Swiss Business & Jobs: Swiss Post plans 110 redundancies, adding pressure to the country’s cost-cutting and workforce reshaping. Finance Watch: UBS wants all new employees to have AI skills, signaling how Swiss banking is rebuilding talent pipelines for automation. Healthcare & Markets: Novartis faces fresh setbacks after a heart-drug trial failure, while Bank Vontobel keeps a Hold on Novartis with a CHF128 target. Energy & Infrastructure: Swiss geothermal drilling in St Gallen could resume, a reminder that local permitting and risk appetite still shape the pace of decarbonisation. Global Trade Risk: Reports allege a Chinese state firm shipped carbon-fibre precursor material to Russia’s drone supply chain—raising sanctions and compliance questions for European supply chains. Sports Business: Former F1 boss Bernie Ecclestone was questioned in Portugal after a shotgun was found on his private jet, underlining how cross-border rules can quickly become reputational and legal issues.
Swiss Markets & Pharma: European shares were subdued as oil prices rose on US-Iran tensions, with Switzerland’s SMI down 1.2% and Novartis sliding 3.3% after its cholesterol drug pelacarsen missed a key late-stage goal, raising pressure on the Swiss pharma pipeline. Insurance & Risk: Swiss Re flagged a growing protection gap in cyber as AI amplifies existing threats, while also warning that storms across Germany, France, Switzerland and Italy in mid-July could cost insurers about €2.186bn. Reinsurance & Capital: Howden Re is building a Zurich-led parametric “International Alternative Solutions” unit, and Swiss Re has completed QBE’s trade credit and surety acquisition. Banking & Fintech: Dukascopy Bank launched AI-powered trading via AI assistants, expanded stock CFDs to 25,000+, and rolled out a new flagship app. Swiss Business & Jobs: Swiss Re Institute says data centres and renewables could drive a global insurance premium “super-cycle” worth $200bn over four years. Swiss Tech & Food Innovation: ETH Zurich developed a freeze-structuring method to turn whole legumes into gel textures for meat-like alternatives. Global Governance: FIFA confirmed Gianni Infantino will seek re-election in 2027 despite UEFA-led calls for him to step down.
FIFA Power Struggle: FIFA confirmed Swiss-Italian boss Gianni Infantino will seek re-election in 2027 despite backlash over the scrapped plan to sell stakes in World Cup commercial rights, with UEFA and others still pushing for him to step aside. Swiss Business & Finance: Swiss Re says “physical economy is back” as data centres become strategic infrastructure, while Swiss inflation and Swiss economy growth stories underline a shifting macro backdrop for banks and insurers. Markets Watch: Analysts weigh in on Kuehne + Nagel (Barclays keeps a Sell) and other financial names, as investors scan for direction amid mixed signals. Travel & Connectivity: American Airlines expands Europe links from New York-JFK with new nonstop routes, while Dubai flight disruptions linger for multiple carriers. Innovation & Industry: Empa and Elantas developed a recyclable epoxy composite with flame-retardant performance. Swiss Economy & Society: A new “wild fish” label initiative by Swiss fishermen and women points to tighter branding in food supply chains.
Swiss Tech & Safety: Switzerland provided Nepal with a Flyability tunnel-rescue drone after the Bhotekoshi flood, designed for dark, narrow, hazardous spaces and to keep flying after collisions. Swiss Business & Finance: UBS expects Panama’s economy to grow about 5% in 2026 as uncertainty fades, construction and tourism recover, and fiscal accounts improve. Swiss Health & Pharma: Roche’s trontinemab is set to be tested in a European trial for people without Alzheimer’s symptoms but at high risk, using blood biomarker screening. Energy & Geopolitics: The US destroyed three Iranian oil tankers amid renewed Iran–US clashes, with knock-on effects for Middle East crude flows. Markets & Macro: US job growth and services activity strengthened, while Europe’s inflation quickened; investors watch next week’s US price data. Crypto & Commodities: Bitcoin’s ratio versus gold jumped as debt and currency-debasement fears lifted both assets. Swiss Watch Industry: Swiss watchmakers face pressure as Gen Z shifts away from traditional status buying, with mid-market brands hit hardest. Aviation: Air travel disruptions continue in the UAE, with delays reported on multiple routes. Climate Risk: El Niño is forecast to strengthen into 2027, raising extreme-weather risk. Corporate/Deal Watch: Roivant and Pulmovant will present Phase 2 PHocus results on mosliciguat at the ERS congress, alongside an investor call.
Swiss Watch Industry: Geneva Watch Days boss Jean-Christophe Babin warns that Gen Z is moving from status to “excitement, emotion, discovery,” squeezing mid-market brands as exports fall. Public Health: A European NHS trial will test an Alzheimer’s drug (Trontinemab) in people without symptoms but at high risk, aiming to delay or prevent onset. Swiss Tech for Disaster Response: Switzerland delivered a Flyability “Flyability” drone to Nepal’s power utility to improve tunnel search-and-rescue and hazardous inspections. Aviation & Travel: Air Canada is adding new nonstop routes for summer 2027, including Basel, plus Nice, Oslo, Shannon, Dubrovnik and Guangzhou. Business & Finance: Swiss Re highlights a “capex super-cycle” in commercial P&C opportunities, while Zurich-based xorlab secured €5m for sovereign email security. Economy & Households: A global savings comparison puts Sweden at the top (16%) while several countries, including South Africa and New Zealand, show negative household saving.
Swiss Finance & Insurance: AM Best affirmed Zurich Insurance Group’s A+ (Superior) financial strength and “aa” long-term issuer credit ratings, with a stable outlook, citing very strong balance sheet strength and risk management ahead of Zurich’s planned Beazley acquisition. Swiss Health & Pharma: Novartis’ experimental pelacarsen failed to cut major heart attack and stroke risk in a late-stage trial despite lowering lipoprotein(a), a setback for its cardiovascular pipeline. Swiss Economy & Society: Switzerland’s gender pay gap keeps narrowing, and the country is moving toward a nationwide conversion therapy ban. Swiss Business & Media: Swiss Films says homegrown and co-produced titles are expanding internationally, with more English-language works drawing attention at major festivals including Venice. Swiss Lifestyle & Cities: A Zürich IT professional is commuting by swimming through the city’s moat, turning a personal routine into a viral story about urban nature. Global Trade Watch (relevant to Swiss firms): Canada and the U.S. are not planning to resume trade talks before Ottawa’s retaliatory tariffs take effect, raising the risk of deeper tariff escalation.
Swiss Economy & Inflation Watch: Switzerland’s inflation rate climbed to 0.8%, the highest since September 2024, adding pressure on households and policy expectations. Banking & Wealth Management: UBS keeps reshuffling its advisor network, reporting three advisor-team wins in the US with $2.6bn in combined client assets moving under UBS umbrellas. Climate Finance for Start-ups: Swiss Re Foundation’s Shine 2027 is offering up to €50,000 grants to early climate tech ventures, including applicants serving Zurich, with applications due Sept. 15. Corporate & Consumer Signals: Barry Callebaut and Arla Foods launch a dairy decarbonisation partnership focused on farm-level carbon data to cut Scope 3 emissions. Markets Mood: US stocks ended the week weaker after strong non-farm payrolls pushed rate-hike expectations higher, a backdrop echoed in Europe’s mixed trading. Business Reality Check: A “Big Mac” affordability comparison suggests Swiss workers buy fewer burgers per hour than Americans, despite higher hourly earnings. Sports & Swiss Links: Swiss right-back Jordan Lotomba joins Celtic on loan/deadline-day timing, highlighting how Swiss talent keeps moving through European club markets.
Swiss Banking & Markets: UBS Group AG has ended its status as a substantial shareholder in Australia’s Cochlear, with changes recorded around 31 Aug and the formal Form 605 filed on 4 Sept. Corporate/Wealth Management: Verium appoints Dominique Wohnlich as a partner to expand wealth management and private markets, drawing on his prior leadership roles at Goldman Sachs Switzerland and Credit Suisse. Energy & Infrastructure: Horizonte Group, Metelligent and Einklang are targeting battery storage for German C&I customers, aiming for 50 joint projects in year one under the MiSpeL framework. EU Policy & Environment: Switzerland will not join the EU’s Copernicus Earth observation programme for now, citing estimated costs of about CHF48m. Retail & Trade: Temu’s “local to local” push is reaching Swiss retailers, but the terms raise questions for consumers about what “local” really means. Shipping & Regulation: A new debate highlights Switzerland’s role in maritime shipping and the need to ensure labour and environmental rules keep pace. Sports Governance: FIFA accuses UEFA of a “smear campaign” in US court filings tied to the World Cup stake-selling plan. Fintech: KPMG’s Pulse of Fintech reports H1 2026 funding in EMEA fell to $11.3bn amid geopolitics, tariffs and rate worries.
Swiss Economy Watch: Switzerland’s SMI edged higher as investors digested data and Middle East risk; meanwhile Swiss inflation jumped to 0.8% in August, driven by energy and housing costs, adding pressure on the outlook. Banking & Markets: NADBank priced a CHF 125m bond (1.125% coupon) in the Swiss market, a sign of continued appetite for cross-border infrastructure finance. Insurance Leadership: Zurich Insurance named new Asia-Pacific leaders for property underwriting and multinational & captives, both based in Singapore. Corporate Moves: Swiss medtech and pharma headlines included Novartis signalling up to 130 job cuts in Basel and Nestlé’s plan to divest vitamins/supplements for about $1bn, while Swiss watch and fintech items kept the business pages busy. Policy & Regulation: Austria published stricter conditions that can block residence permits for third-country nationals, highlighting tighter compliance expectations across Europe. Global Business Flash: FIFA and UEFA escalated their World Cup dispute in US court filings, while US drone tariffs up to 100% and a widening US trade deficit fed broader trade-and-inflation concerns.
Swiss Macro: Switzerland’s economy grew 1.5% in Q2 2026, the fastest pace in nearly five years, driven by a sharp acceleration in chemicals and pharmaceuticals exports and sales. EU Security: The EU is weighing responses to a failed Russia-blamed drone attack on Leipzig/Halle airport, with sanctions, visa curbs and consulate closures on the table. US Trade & Industry: New US tariffs of up to 100% on imported drones and key components took effect, with lower ceilings for some Swiss-origin goods. Swiss Pharma & China: Swissinfo reports China’s pharma boom is reshaping drug pipelines and competition for Swiss giants like Roche and Novartis, while Switzerland’s vitamin production faces pressure from expanding Chinese capacity. Swiss Business & Transport: SBB is criticised after a blog post suggested passengers travel off-peak for empty seats, sparking debate over capacity and pricing. Healthcare Deals: Nxera Pharma says Centessa’s late-stage milestone triggers an $8.6m payment, highlighting ongoing Swiss-linked biotech licensing momentum. Energy/Geopolitics: Trump’s renewed push on Iran and oil-price expectations continues to move FX and markets, with USD/JPY reacting to BoJ hike bets.
Swiss Pharma & Jobs: Novartis plans to discontinue small-volume biologics production at its Kleinbasel site by end-2027, potentially cutting around 130 jobs, while shifting cell-bank, testing and technical development work to Basel campus by end-2028. Banking Regulation: Swiss lawmakers move to soften UBS capital rules after an interim win in the fight over foreign unit capital demands, keeping the debate on how much regulation is “enough” for global banks. Markets & Rates: European stocks slipped as oil rose on Middle East tensions and bond-yield fears returned; Switzerland’s SMI managed a small gain on late buying. Tokenised Finance: Zug-based Centrifuge says tokenised assets hit about $1.6bn in value locked, with holders up 23% in a month, led by Janus Henderson-managed tokenised US Treasuries and CLO exposure. Swiss Business Abroad: ADAPT Investment Managers opened its fourth global office in Abu Dhabi to deepen MENA coverage, joining existing Geneva, Zug and New York operations. Trade & Food: Egyptian Swiss Group prepares to export pasta and flour to China for the first time after completing customs and regulatory steps. Health Innovation: EU approves Hopledo (modified-release carbidopa/levodopa) for Parkinson motor fluctuations, with phased rollout expected from October 2026.
Telecom Spectrum Auction: Switzerland’s telecom regulator ComCom has launched an auction for key frequency bands (800/900/1800/2100/2600 MHz), with applications due 3 Dec and awards planned for Q2 2027. Corporate Restructuring: Swiss Life plans about 600 job cuts by end-2028 (half in Switzerland) alongside stronger H1 profits and a CHF 250m share buy-back. Banking Regulation & Hiring: Deutsche Bank Private Bank in Switzerland adds senior Financial Intermediaries leaders from Julius Baer to expand its EAM/FIM business across Europe and beyond. M&A in Consumer Health: Nestlé will sell its mainstream vitamins, minerals and supplements unit to US PE Yellow Wood Partners for $1bn, as it streamlines around core growth areas. Energy & Geopolitics: Chevron plans to expand in Venezuela as Washington pushes a broader oil deal that includes a Pentagon stake, raising legal and political questions. Markets & Rates: European shares slide toward a one-month low as bond yields rise and euro-zone inflation keeps ECB rate-hike expectations alive. Gold Demand: Near-record gold price gains pull in heavy private investor buying, with demand outpacing selling. Business Tech & Biotech Funding: DataHow secures bridge financing to accelerate DataHowLab expansion, while NewBiologix and Synastra sign to advance stable rAAV manufacturing for Duchenne gene therapy. Swiss AI Reality Check: A year after launch, Switzerland’s open AI model Apertus hits 4m downloads but still struggles on key tasks.
Swiss Markets: The SMI ended up 0.34% at 14,334.79, helped by stronger July retail sales despite worries over rates and global growth. UBS Capital Fight: Swiss lawmakers backed a softer approach to UBS capital rules, a move that keeps the bank’s regulatory battle in focus. Pharma Watch: Novartis paused eight autoimmune drug trials after three deaths tied to a severe immune reaction, while a separate Phase 3 readout for an MS pill (remibrutinib) boosted confidence. Corporate Moves (Switzerland): Sudarshan agreed to buy Clariant’s aluminium dyes plant in Muttenz, taking control of a key supply site ahead of a 2027 close. Tech & Security: xorlab secured €5m to scale sovereign email security across Europe, and Swiss banking/ID-related policy debates continue as governments push for tighter controls. Global Risk Mood: Europe’s stocks slipped as bond yields rose and geopolitical tensions weighed sentiment.
UBS Capital Fight: Swiss lawmakers backed a compromise that lets UBS meet up to half of tougher capital needs using AT1 convertible debt (instead of only top-quality CET1), while still requiring full backing of foreign subsidiaries at the Swiss parent level—an interim win in the bank’s pushback against “draconian” rules. Swiss Policy Changes: From Sept. 1, canton Bern’s revised data protection law expands cantonal oversight, while Basel City rolls out civil-service pay measures. Cuba Trade Pressure: Swiss firms report shrinking trade with Cuba as US sanctions make bank transfers and collections increasingly difficult, with Swiss exports down sharply in 2026. Novartis Safety Pause: Novartis temporarily halted eight CAR-T trials after three deaths linked to a severe immune response, with independent safety boards and regulators in the loop. Vetropack Decommissioning: Vetropack completed dismantling of furnace 21 at St-Prex, shipping out recycled glass and quartz sand and moving into final decommissioning stages. Remote Work Demand: A Swiss jobs analysis finds nearly one in seven adverts now offers home-office options, pushing employers to adapt recruitment practices. Cybersecurity Funding: xorlab raised €5m to expand its email security platform across Europe.
UBS Capital Reform: Switzerland’s upper-house Economic Affairs committee backed a “softer” UBS capital compromise, allowing up to 50% of extra capital needs to be met with reformed AT1 convertible debt—setting up a key legislative fight over how much buffer is enough after Credit Suisse’s collapse. Swiss Finance Watch: The Swiss Bankers Association welcomed the AT1 reform direction but rejected tighter capital requirements, keeping pressure on the finance ministry. Swiss Market Mood: The Swiss stock market slipped about 0.8% on geopolitical concerns, with investors also wary of rate expectations. Banking & Payments: Visa and Mastercard move to simplify global transfers from Switzerland, while Swiss banks push ahead with capital and infrastructure upgrades. Zurich Corporate Moves: Zurich laments the departure of Bank Vontobel, as the Swiss wealth-management landscape keeps reshuffling. Business Infrastructure (Global, Swiss-linked): A Swiss Challenge-style process in New Clark City grants original proponent status to a Maynilad–K-Water consortium, highlighting how PPP procurement rules can accelerate major water projects.
Swiss Banking: Swiss lawmakers are set to decide on UBS capital rules, with a watered-down draft likely allowing foreign subsidiaries to be backed by 50% CET1 (vs the government’s 100% demand), using cheaper AT1 to fill gaps—an immediate test of how Switzerland balances stability and competitiveness. Corporate Deal: Samsung Biologics will launch its September takeover of PolyPeptide Group, offering CHF 44.31 per share (about CHF 1.46bn total) with an offer period from Sept. 15 to Oct. 12, and PolyPeptide’s board unanimously recommending acceptance. Tech & Finance Risk: Bank of England governor Andrew Bailey warns frontier AI could destabilise the global financial system via cyber disruption, urging better cross-border protocols for development and deployment. Business & Trade: Switzerland plans to upgrade its free trade agreement with China, raising questions for Swiss firms about tariff relief versus political and human-rights backlash. Swiss Economy & Society: A Swiss apprenticeship model story highlights how modern vocational training could help address US-style skills shortages. Energy/Industry: AkzoNobel and Axalta move ahead on their merger of equals, naming directors to finalise the combined-company board.
Swiss Security & Public Safety: Police are hunting a suspect after a deadly shooting at a techno rave in Aarau (Aargau) left 1 woman dead and 5 others injured, with organisers expecting up to 3,500 people. Corporate Switzerland in the Spotlight: Galderma, the Switzerland-based dermatology group, inaugurated its new U.S. and Latin America headquarters in Miami, aiming to speed decisions and expand training for its injectable and skincare businesses. Swiss Business & Regulation Watch: An incoming Swiss banking lobby chief warns against over-regulation, as Switzerland’s financial sector faces renewed scrutiny. Economy & Markets: Rabobank’s global dairy ranking puts Nestlé (Switzerland) in the top three and Emmi (Switzerland) in the top 20, highlighting consolidation and value focus. Tech & Industry: ABB and Nüvü Camēras supplied camera readout electronics for NASA’s Nancy Grace Roman Space Telescope, launched to study exoplanets. Fraud Alert: A fake “49ers player” scamster allegedly defrauded women out of about $1.8m, using stolen NFL photos and videos to lure victims.
Aarau Rave Shooting: Police in Switzerland’s Aargau canton say one person was killed and at least five were injured, some seriously, after gunshots at a rave near the Schachen horse-racing track; a manhunt is under way and authorities asked the public to share any photos or video. Public Safety & Gun Policy: The incident comes despite Switzerland’s relatively rare violent shootings, even as the country has tightened gun control rules since 2019. Swiss Spotlight Abroad (Sports): Roger Federer was brought to tears during his induction speech into the International Tennis Hall of Fame in Newport, with tributes to his family and longtime coach. AI & Information Integrity: An NPR/NewsGuard test found AI chatbots generally push back better than search summaries against foreign false narratives, though caution is still advised. Currency Watch: The Swiss franc was among major currencies that slipped in a recent exchange-rate update, with the pound also moving lower. Disaster Impact (Global): Nepal’s flash-flood death toll rose to 675 as rescuers continued searches for thousands missing, including hundreds of foreign nationals.
Sign up for:
Business Daily Switzerland
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.